Class Action Lawsuits Filed Over Drug Co-Pay Subsidy Programs
Eight major drug manufacturers face class action lawsuits over popular co-pay coupon programs, which reduce the amount consumers pay for prescription drugs, but may increase the overall costs for the...
View ArticleDrug Maker Overhyped, Oversold Anemia Meds: Report
Three popular anemia drugs, Epogen, Procrit and Aranesp, may be far less effective, and far more dangerous, than their manufacturer led the public and experts to believe, according to an investigative...
View ArticleXgeva, Prolia Bone Drugs Linked to Deadly Low Calcium Levels
Individuals in multiple countries are being warning about potentially life-threatening health risks associated with low calcium levels that may be caused by side effects of the bone drugs Xgeva and...
View ArticleAranesp Settlement Results in $762M Payment by Amgen
Amgen has agreed to pay $762 million to settle a whistleblower lawsuit and criminal charges this week, which allege that the drug maker illegally promoted their anemia medications Aranesp and Epogen....
View ArticleProlia Femur Fracture Warning Issued to Doctors in Canada
A warning has been provided by Canadian health officials about the potential risk of sudden femur fractures associated with side effects of Prolia, an osteoporosis drug sold by Amgen. However, it does...
View ArticleAranesp Fails to Help Heart Failure Patients in Clinical Trial
The anemia drug Aranesp, known generically as darbepoetin alfa, failed in clinical trials to treat heart failure and led to some participants experiencing serious adverse side effects, according to...
View ArticleFDA Halts Pediatric Trials for Sensipar After Teen’s Death
Following the death of a 14-year-old test subject, federal health regulators have forced Amgen to halt pediatric trials of the drug Sensipar (cinacalcet), which is currently only approved for use by...
View ArticleFor-Profit Dialysis Centers May Have Ignored Anemia Drug Warnings: Study
Even after the FDA warned that anemia drugs like Aranesp, Epogen and Procrit could increase the risk of death among patients, for-profit dialysis centers continued to use them more than non-profit...
View ArticleProlia Side Effects Increase Risk of Low-Trauma Fractures: Public Citizen
A prominent consumer watchdog group is warning that the Amgen bone drug Prolia could increase the risk of sudden bone fractures, which may occur with little or no trauma at all. In the latest edition...
View ArticleEnbrel Schizophrenia Symptoms Reviewed by Health Canada
In response to concerns raised by a recent medical journal report, Canadian health officials indicate that they have conducted a safety review to evaluate the potential side effects of Enbrel and...
View ArticlePraluent, Repatha Costs Outweigh Health Benefits: Study
The high price tag on two new cholesterol-fighting drugs may be so high that it is not worth the cost to take them, according to a new report. A draft report (PDF) released last week by the Institute...
View ArticleProlia and Xgeva Side Effects May Include Heart Rhythm Risks, Australia Warns
Drug regulators in Australia are warning that the bone drugs Prolia and Xgeva, both of which use the active ingredient denosumab and are also available in the United States, could cause users to suffer...
View ArticleAranesp Stevens-Johnson Syndrome Warning Issued By Canadian Health Officials
Canadian health experts are warning about the risk of a severe and potentially life-threatening skin reactions, known as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which have...
View ArticleRepatha, Similar Cholesterol Drugs, Overpriced For Benefits They Provide: Study
A new study warns that Repatha and similar new cholesterol drugs may be significantly overpriced in the U.S. due to the limited benefits patients may receive from these injectable medications....
View ArticleKyprolis Side Effects May Increase Risks of Heart Problems, Researchers Warn
Side effects of the multiple myeloma drug Kyprolis may increase the risk of cardiac arrest and other heart problems, according to the findings of new research. Kyprolis (carfilzomib) is an Amgen drug,...
View ArticleProlia Fracture Risk Leads Public Citizen to Call For Black Box Warning
The consumer watchdog group Public Citizen is asking federal regulators to add a black box warning to Prolia, an osteoporosis drug that has been linked to an increased risk of bone fractures. Public...
View ArticleProlia Discontinuation Increases The Risk Of Vertebral Fractures, Study Found
The side effects of Prolia may increase the risk of vertebral fractures when consumers stop using the osteoporosis drug, according to the findings of a study by Israeli researchers. In research...
View ArticleProlia Lawsuit
Increasing evidence suggests that side effects of the osteoporosis drug Prolia may increase the risk of hip fractures, femur fractures and other bone fractures, which typically occur following minimal...
View ArticleFor-Profit Dialysis Centers May Have Ignored Anemia Drug Warnings: Study
Even after the FDA warned that anemia drugs like Aranesp, Epogen and Procrit could increase the risk of death among patients, for-profit dialysis centers continued to use them more than non-profit...
View ArticleProlia Side Effects Increase Risk of Low-Trauma Fractures: Public Citizen
A prominent consumer watchdog group is warning that the Amgen bone drug Prolia could increase the risk of sudden bone fractures, which may occur with little or no trauma at all. In the latest edition...
View Article
